Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on UNITED CACAO LTD SEZC. We currently have 32 research reports from 3 professional analysts.
|25Jan17 12:44||RNS||Funding Update|
|25Jan17 12:43||RNS||Corporate Update|
|09Jan17 17:03||RNS||Funding Update - Clarification|
|06Jan17 07:00||RNS||Directorate Changes|
|06Jan17 07:00||RNS||Funding Update|
|05Jan17 07:00||RNS||Resignation of NEX Exchange Corporate Adviser|
|04Jan17 16:10||RNS||Resignation of Nominated Adviser|
Frequency of research reports
Research reports on
UNITED CACAO LTD SEZC
UNITED CACAO LTD SEZC
Small Cap Breakfast
07 Dec 16
Creo Medical group—Schedule 1 update.. £20m raise. Expected market cap £61.2m, admission expected 9 December. ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m. RM Secured Direct Lending - The secured direct lending fund intends to float on the Main Market on 15 December raising up to £100m
The Monthly November 2016
01 Nov 16
Share prices are built on expectations - expectations about all sorts of things, such as a company’s future sales growth, the trend in margins and the profits it can return. Understanding those expectations and how they move is critical to share price formation. Listing rules require quoted companies to update investors on progress relative to expectations. What managements often fail to understand is that many of their key investors do not have access to brokers’ research and, thus, cannot put management statements into context. It is these very investors that can cause shock movements in share prices on announcements in limited trading.
03 Oct 16
Many commentators realise that the traditional institutional broking model is no longer sustainable. However, the reduction in the quantity of non-corporate coverage that has already occurred, even before MiFID2 comes into effect, will still come as a shock. The evidence shows that there is no commercial sense in brokers covering non-corporate companies with less that £200,000 daily turnover in their shares.
The Impact of Brexit
01 Sep 16
The dramatic – and historic – vote on June 23rd for the UK to exit the EU caught many organisations short, not least the EU itself. Both stock markets and currency markets were anticipating a narrow majority for the UK to remain within the EU – on a similar basis to the 2014 Scottish referendum. But it was not to be. As a result, the financial markets have reacted sharply in recent months, although other non- Brexit factors have also come into the equation.
20 Apr 17
Although the last two months have seen a broadly neutral performance from the UK healthcare sector compared to a significantly more volatile 6 months prior, we continue to expect macro-events and increased geo-political risk to result in an overall neutral performance from the sector over the next period. However, company specific news is likely to drive a strong outperformance from selected mid-market companies. We retain our neutral sector stance whilst highlighting those we expect to outperform.
Positioned to perform
08 Mar 17
Stock Spirits (STCK LN, BUY, T/P 240p) preliminary 2016 results were in line with expectations, reconfirming their 11th January 2017 trading statement. Adjusted EBITDA was €51.5m compared with Bloomberg consensus and Whitman Howard estimates of €50.0m. The company are hosting an analyst presentation at 9.00am.
03 Apr 17
After much heralding, MIFID II is finally beginning to have an impact on the business of investment research, though its true ramifications might take years to be seen. The role of analyst research is widely misunderstood. It is not all about the conclusion: the rating and price target. The real content of research is about what is discounted in the current share price and what assumptions would produce different outcomes.
Feeling good about growth prospects
13 Apr 17
In our view Nichols (NICL LN, BUY, T/P 2300p) remains well positioned to grow. Its core Vimto business’s strong performances in both the UK and Middle East enjoy significant intra-regional geographic growth opportunities as well as generating enough free cash flow to fund NPD and selective M&A. Moreover, we argue that the company’s very virtuous outsourcing business model merits a premium valuation. We raise our price target from 1760p to 2300p. BUY.
Undevilish detail implies more upside to come
09 Mar 17
While Stock Spirits (STCK LN, BUY, T/P 240p) appears in better shape than for some time, further improvements seem likely. Polish vodka market conditions remain competitive. But in our view attention to detail suggests the company is implementing the right brand strategy, appropriate pricing architecture and upgraded its sales function – hence, more upside to come. BUY